HELP
Cybin D/B/A Helus Pharma
Price Chart
No historical data available
Latest Quote
$11.70
-0.06 (-0.51%)
Current Price
| Previous Close | $11.76 |
| Open | $11.76 |
| Day High | $11.90 |
| Day Low | $11.50 |
| Volume | 97,716 |
Stock Information
Note: Financial values converted from CAD to USD
| Shares Outstanding | 73.06M |
| Cash Equivalents | $149K |
| Net Income | $-123.34M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $854.80M |
| EPS (TTM) | $-4.06 |
| Exchange | NGM |
Recent Price History
No history data available. Data will be fetched automatically.
About Cybin D/B/A Helus Pharma
Cybin Inc., doing business as Helus Pharma, a clinical stage pharmaceutical company, focuses on developing therapies to treat various psychiatric and neurological conditions.It develops HLP003, a deuterated psilocybin analog, which is in phase 3 clinical trial to treat major depressive disorder (MDD); and HLP004, a deuterated N, N-dimethyltryptamine (DMT), which is in phase 2 clinical trial for treating generalized anxiety disorders. The company' preclinical product includes HLP005, a phenethylamine and tryptamine derivative to treat central nervous system. It has a strategic partnership agreement with Segal Trials to evaluating HLP003 for the adjunctive treatment of major depressive disorder; and with Osmind for mental health treatments. The company is headquartered in Toronto, Canada.
đ° Latest News
No news articles available at the moment. Check back later for updates on HELP.
Period:
Loading...
Income Statement (Annual)
| Metric | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $0 | $0 | $0 | $0 |
| Operating Revenue | $0 | $0 | $0 | $0 |
| Reconciled Cost Of Revenue | - | - | - | - |
| Cost Of Revenue | - | - | - | - |
| Expenses | ||||
| Total Expenses | $102,300,897 | $73,988,372 | $56,561,913 | $36,962,259 |
| Other Income Expense | $-5,448,414 | $11,155,115 | $98,292 | $2,457,311 |
| Other Non Operating Income Expenses | $-1,855,359 | - | - | - |
| Net Non Operating Interest Income Expense | $1,566,222 | $4,297,603 | $444,110 | $432,630 |
| Total Other Finance Cost | $2,092,840 | - | - | - |
| Operating Expense | $102,300,897 | $73,988,372 | $56,561,913 | $36,962,259 |
| Selling And Marketing Expense | $4,626,201 | $1,688,190 | $2,012,953 | $632,085 |
| General And Administrative Expense | $35,551,009 | $44,167,740 | $22,663,909 | $18,041,325 |
| Interest Expense | - | - | - | - |
| Interest Expense Non Operating | - | - | - | - |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-106,183,089 | $-58,550,003 | $-56,019,511 | $-34,072,318 |
| Net Interest Income | $1,566,222 | $4,297,603 | $444,110 | $432,630 |
| Interest Income | $3,659,061 | $4,297,603 | $444,110 | $432,630 |
| Normalized Income | $-102,590,034 | $-69,705,118 | $-56,117,803 | $-36,529,629 |
| Net Income From Continuing And Discontinued Operation | $-106,183,089 | $-58,550,003 | $-56,019,511 | $-34,072,318 |
| Net Income Common Stockholders | $-106,183,089 | $-58,550,003 | $-56,019,511 | $-34,072,318 |
| Net Income | $-106,183,089 | $-58,550,003 | $-56,019,511 | $-34,072,318 |
| Net Income Including Noncontrolling Interests | $-106,183,089 | $-58,535,654 | $-56,019,511 | $-34,072,318 |
| Net Income Continuous Operations | $-106,183,089 | $-58,535,654 | $-56,019,511 | $-34,072,318 |
| Pretax Income | $-106,183,089 | $-58,535,654 | $-56,019,511 | $-34,072,318 |
| Interest Income Non Operating | $3,659,061 | $4,297,603 | $444,110 | $432,630 |
| Operating Income | $-102,300,897 | $-73,988,372 | $-56,561,913 | $-36,962,259 |
| Special Income Charges | - | $-20,089 | $0 | $-245,372 |
| Gross Profit | - | - | - | - |
| Per Share | ||||
| Diluted EPS | - | $-2.90 | $-5.00 | $-7.09 |
| Basic EPS | - | $-2.90 | $-5.00 | $-7.09 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-98,621,747 | $-84,893,809 | $-56,356,001 | $-39,239,486 |
| Total Unusual Items | $-3,593,055 | $11,155,115 | $98,292 | $2,457,311 |
| Total Unusual Items Excluding Goodwill | $-3,593,055 | $11,155,115 | $98,292 | $2,457,311 |
| Reconciled Depreciation | $86,096 | $249,677 | $304,204 | $180,083 |
| EBITDA (Bullshit earnings) | $-102,214,801 | $-73,738,695 | $-56,257,709 | $-36,782,176 |
| EBIT | $-102,300,897 | $-73,988,372 | $-56,561,913 | $-36,962,259 |
| Diluted NI Availto Com Stockholders | $-106,183,089 | $-58,550,003 | $-56,019,511 | $-34,072,318 |
| Gain On Sale Of Security | $-3,593,055 | $11,155,115 | $98,292 | $2,702,683 |
| Research And Development | $62,123,686 | $28,132,442 | $23,218,538 | $18,288,849 |
| Selling General And Administration | $40,177,211 | $45,855,930 | $33,343,375 | $18,673,410 |
| Other Gand A | $20,607,690 | $14,964,126 | $10,911,151 | $10,179,365 |
| Salaries And Wages | $14,943,319 | $29,203,614 | $15,880,326 | $7,861,960 |
| Diluted Average Shares | - | $14,508,890 | $5,953,056 | $3,501,007 |
| Basic Average Shares | - | $14,508,890 | $5,953,056 | $3,501,007 |
| Other Special Charges | - | $20,089 | - | - |
| Restructuring And Mergern Acquisition | - | - | $0 | $245,372 |
| Write Off | - | - | - | - |
| Impairment Of Capital Assets | - | - | - | - |
Fetched: 2026-08-09
Balance Sheet (Annual)
| Metric | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $118,625,332 | $72,212,651 | $149,940,440 | $12,894,245 |
| Total Assets | $180,202,312 | $129,069,441 | $216,690,328 | $38,669,103 |
| Total Non Current Assets | $47,814,604 | $46,236,903 | $59,898,833 | $22,034,724 |
| Goodwill And Other Intangible Assets | $47,674,699 | $46,166,592 | $59,506,381 | $21,711,865 |
| Other Intangible Assets | $21,684,602 | $20,470,654 | $25,444,825 | $3,924,523 |
| Current Assets | $132,387,708 | $82,832,538 | $156,791,494 | $16,634,380 |
| Prepaid Assets | $15,953,507 | $11,057,540 | $2,074,186 | $1,243,363 |
| Receivables | $3,607,404 | $2,937,294 | $3,211,364 | $2,188,262 |
| Accounts Receivable | $3,607,404 | $2,937,294 | $3,211,364 | $2,188,262 |
| Cash Cash Equivalents And Short Term Investments | $112,826,796 | $67,385,560 | $149,944,027 | $11,933,562 |
| Cash And Cash Equivalents | $112,826,796 | $67,385,560 | $149,944,027 | $11,933,562 |
| Cash Financial | $112,826,796 | $67,385,560 | $149,944,027 | $11,933,562 |
| Other Current Assets | - | $1,452,145 | $1,561,917 | $1,269,192 |
| Debt | ||||
| Total Debt | - | $0 | $208,782 | - |
| Current Debt And Capital Lease Obligation | - | - | $208,782 | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $13,902,281 | $10,690,199 | $7,243,506 | $4,062,993 |
| Total Non Current Liabilities Net Minority Interest | $0 | $0 | $0 | $0 |
| Current Liabilities | $13,902,281 | $10,690,199 | $7,243,506 | $4,062,993 |
| Payables And Accrued Expenses | $13,902,281 | $10,690,199 | $5,206,279 | $4,062,993 |
| Payables | - | $15,366,623 | $5,206,279 | $4,062,993 |
| Accounts Payable | - | $15,366,623 | $7,034,725 | $4,062,993 |
| Other Payable | - | - | $208,782 | - |
| Tradeand Other Payables Non Current | - | - | - | - |
| Other Non Current Liabilities | - | - | - | - |
| Other Current Liabilities | - | - | - | - |
| Equity | ||||
| Common Stock Equity | $166,300,031 | $118,379,243 | $209,446,821 | $34,606,110 |
| Total Equity Gross Minority Interest | $166,300,031 | $118,379,243 | $209,446,821 | $34,606,110 |
| Stockholders Equity | $166,300,031 | $118,379,243 | $209,446,821 | $34,606,110 |
| Other Equity Interest | $61,821,634 | $40,719,613 | $46,503,082 | $27,375,518 |
| Gains Losses Not Affecting Retained Earnings | $5,799,253 | $-10,256,851 | $-1,639,403 | $-1,460,037 |
| Other Equity Adjustments | $5,799,253 | $-10,256,851 | $-1,639,403 | $-1,460,037 |
| Retained Earnings | $-279,476,950 | $-183,235,028 | $-162,312,372 | $-106,292,861 |
| Other | ||||
| Ordinary Shares Number | $37,043,909 | $15,504,881 | $14,350,948 | $3,697,941 |
| Share Issued | $37,043,909 | $15,504,881 | $14,350,948 | $3,697,941 |
| Tangible Book Value | $118,625,332 | $72,212,651 | $149,940,440 | $12,894,245 |
| Invested Capital | $166,300,031 | $118,379,243 | $209,446,821 | $34,606,110 |
| Working Capital | $118,485,427 | $72,142,340 | $149,547,988 | $12,571,387 |
| Total Capitalization | $166,300,031 | $118,379,243 | $209,446,821 | $34,606,110 |
| Additional Paid In Capital | $25,091,116 | $23,407,948 | $8,430,190 | $1,508,107 |
| Capital Stock | $353,064,977 | $247,743,561 | $318,465,324 | $113,475,383 |
| Common Stock | $353,064,977 | $247,743,561 | $318,465,324 | $113,475,383 |
| Goodwill | $25,990,097 | $25,695,937 | $34,061,556 | $17,787,343 |
| Net PPE | $139,905 | $70,311 | $392,452 | $322,858 |
| Accumulated Depreciation | $-441,957 | $-422,586 | $-578,993 | $-325,011 |
| Gross PPE | $581,862 | $492,897 | $971,445 | $647,869 |
| Other Properties | $296,312 | $342,230 | $780,600 | $476,395 |
| Machinery Furniture Equipment | $285,550 | $150,667 | $190,845 | $171,474 |
| Capital Lease Obligations | - | $0 | $208,782 | - |
| Current Capital Lease Obligation | - | $0 | $208,782 | - |
| Treasury Shares Number | - | - | $0 | - |
| Investments And Advances | - | - | - | $0 |
Fetched: 2026-08-09
Cash Flow Statement (Annual)
| Metric | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-96,602,088 | $-52,894,242 | $-49,948,339 | $-36,404,073 |
| Operating Activities | ||||
| Operating Cash Flow | $-95,617,011 | $-51,892,664 | $-49,438,940 | $-34,029,988 |
| Cash Flow From Continuing Operating Activities | $-95,617,011 | $-51,892,664 | $-49,438,940 | $-34,029,988 |
| Operating Gains Losses | $-358,014 | $-11,155,115 | $-98,292 | $-2,887,789 |
| Investing Activities | ||||
| Capital Expenditure | $-985,077 | $-1,001,578 | $-509,399 | $-2,374,085 |
| Investing Cash Flow | $-977,902 | $-1,001,578 | $4,966,279 | $-2,374,085 |
| Cash Flow From Continuing Investing Activities | $-977,902 | $-1,001,578 | $4,966,279 | $-2,374,085 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $104,786,906 | $10,263,308 | $182,666,080 | $9,471,947 |
| Financing Cash Flow | $142,229,148 | $10,112,641 | $182,599,356 | $9,731,668 |
| Cash Flow From Continuing Financing Activities | $142,229,148 | $10,112,641 | $182,599,356 | $9,731,668 |
| Net Other Financing Charges | $-226,001 | - | - | - |
| Net Common Stock Issuance | $104,786,906 | $10,263,308 | $182,666,080 | $9,471,947 |
| Common Stock Issuance | $104,786,906 | $10,263,308 | $182,666,080 | $9,471,947 |
| Other | ||||
| Repayment Of Debt | $-14,456,879 | $-150,667 | $-106,902 | $0 |
| Issuance Of Debt | $31,927,104 | $0 | - | - |
| End Cash Position | $112,826,796 | $67,385,560 | $149,944,027 | $11,933,562 |
| Beginning Cash Position | $67,385,560 | $110,660,058 | $11,933,562 | $38,485,433 |
| Effect Of Exchange Rate Changes | $-192,998 | $-492,897 | $-116,229 | $120,534 |
| Changes In Cash | $45,634,234 | $-42,781,601 | $138,126,694 | $-26,672,404 |
| Proceeds From Stock Option Exercised | $20,198,018 | $0 | $40,178 | $259,722 |
| Net Issuance Payments Of Debt | $17,470,224 | $-150,667 | $-106,902 | $0 |
| Net Short Term Debt Issuance | $17,470,224 | $0 | - | - |
| Short Term Debt Payments | $-14,456,879 | $0 | - | - |
| Short Term Debt Issuance | $31,927,104 | $0 | - | - |
| Net Long Term Debt Issuance | $0 | $-150,667 | $-106,902 | $0 |
| Long Term Debt Payments | $0 | $-150,667 | $-106,902 | $0 |
| Net PPE Purchase And Sale | $-977,902 | $-1,001,578 | $-376,997 | $-101,880 |
| Sale Of PPE | $7,175 | $0 | - | - |
| Purchase Of PPE | $-985,077 | $-1,001,578 | $-376,997 | $-101,880 |
| Change In Working Capital | $-901,851 | $-4,895,250 | $-3,606,687 | $-1,030,994 |
| Change In Other Current Assets | $1,452,145 | $-299,182 | $-292,725 | $-307,074 |
| Change In Payables And Accrued Expense | $3,212,082 | $5,497,202 | $-1,825,226 | $287,703 |
| Change In Prepaid Assets | $-4,895,968 | $-9,526,474 | $-707,419 | $-331,468 |
| Change In Receivables | $-670,110 | $-566,796 | $-781,317 | $-680,155 |
| Changes In Account Receivables | $-670,110 | $-566,796 | $-781,317 | $-680,155 |
| Stock Based Compensation | $7,793,801 | $22,443,678 | $9,962,691 | $3,362,032 |
| Unrealized Gain Loss On Investment Securities | $3,946,046 | $0 | $0 | $186,540 |
| Depreciation Amortization Depletion | $86,096 | $249,677 | $304,204 | $180,083 |
| Depreciation And Amortization | $86,096 | $249,677 | $304,204 | $180,083 |
| Amortization Cash Flow | $22,959 | $46,635 | $43,765 | $26,546 |
| Amortization Of Intangibles | $22,959 | $46,635 | $43,765 | $26,546 |
| Depreciation | $63,137 | $294,160 | $260,439 | $153,537 |
| Net Foreign Currency Exchange Gain Loss | $-352,992 | $-11,155,115 | $-98,292 | $-2,887,789 |
| Gain Loss On Sale Of PPE | $-5,022 | $0 | - | - |
| Net Income From Continuing Operations | $-106,183,089 | $-58,550,003 | $-56,019,511 | $-34,072,318 |
| Net Business Purchase And Sale | - | $0 | $5,475,678 | $0 |
| Sale Of Business | - | $0 | $5,475,678 | $0 |
| Other Non Cash Items | - | $14,349 | $5,740 | $232,458 |
| Asset Impairment Charge | - | $0 | $12,914 | $0 |
| Net Intangibles Purchase And Sale | - | - | $-494,332 | $-2,272,205 |
| Purchase Of Intangibles | - | - | $-494,332 | $-2,272,205 |
| Net Investment Purchase And Sale | - | - | - | $0 |
| Purchase Of Investment | - | - | - | $0 |
| Purchase Of Business | - | - | - | - |
| Change In Inventory | - | - | - | - |
| Gain Loss On Investment Securities | - | - | - | - |
Fetched: 2026-08-09